114 related articles for article (PubMed ID: 3523119)
1. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus.
Van Haeften TW; Bolli GB; Dimitriadis GD; Gottesman IS; Horwitz DL; Gerich JE
Metabolism; 1986 Jul; 35(7):649-56. PubMed ID: 3523119
[TBL] [Abstract][Full Text] [Related]
2. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
de Meijer PH; Lutterman JA; van't Laar A
Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
[TBL] [Abstract][Full Text] [Related]
4. Insulin antibody binding in diabetes mellitus and factitious hypoglycemia.
Palumbo PJ; Molnar GD; Taylor WF; Moxness KE; Tauxe WN
Mayo Clin Proc; 1969 Oct; 44(10):725-37. PubMed ID: 5344806
[No Abstract] [Full Text] [Related]
5. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
Navalesi R; Pilo A; Ferrannini E
J Clin Invest; 1978 Jan; 61(1):197-208. PubMed ID: 338630
[TBL] [Abstract][Full Text] [Related]
7. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.
Bolli GB; Dimitriadis GD; Pehling GB; Baker BA; Haymond MW; Cryer PE; Gerich JE
N Engl J Med; 1984 Jun; 310(26):1706-11. PubMed ID: 6374455
[TBL] [Abstract][Full Text] [Related]
8. Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion.
Slama G; Buu KN; Tchobroutsky G; Delage A; Desplanque N
Diabetes Care; 1979; 2(3):251-5. PubMed ID: 510116
[TBL] [Abstract][Full Text] [Related]
9. Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients.
Waldhäusl WK; Bratusch-Marrain P; Kruse V; Jensen I; Nowotny P; Vierhapper H
Diabetes; 1985 Feb; 34(2):166-73. PubMed ID: 3881304
[TBL] [Abstract][Full Text] [Related]
10. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens.
Van Haeften TW; Heiling VJ; Gerich JE
Diabetes; 1987 Mar; 36(3):305-9. PubMed ID: 3542653
[TBL] [Abstract][Full Text] [Related]
12. Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics.
Van Haeften TW; Krom BA; Gerich JE
Diabetes Care; 1987; 10(2):160-3. PubMed ID: 3582076
[TBL] [Abstract][Full Text] [Related]
13. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
14. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
[TBL] [Abstract][Full Text] [Related]
15. Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.
De Feo P; Perriello G; Ventura MM; Calcinaro F; Basta G; Lolli C; Cruciani C; Dell'Olio A; Santeusanio F; Brunetti P
Diabetologia; 1986 Aug; 29(8):475-80. PubMed ID: 3530862
[TBL] [Abstract][Full Text] [Related]
16. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.
Francis AJ; Hanning I; Alberti KG
Diabetologia; 1985 Jun; 28(6):330-4. PubMed ID: 3899818
[TBL] [Abstract][Full Text] [Related]
17. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
Asplin CM; Hartog M; Goldie DJ
Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
[TBL] [Abstract][Full Text] [Related]
18. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
Shahshahani MN; Kitabchi
J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
[TBL] [Abstract][Full Text] [Related]
19. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
[TBL] [Abstract][Full Text] [Related]
20. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
